News
University of Birmingham Team Developing Point-of-Care Test for Multiple Myeloma Precursor Condition
The lateral flow, fingerprick blood test measures monoclonal proteins, with results that can be read on a phone app.
The test, which aids in the detection of the brain amyloid pathology characteristic of Alzheimer's, is the first blood test cleared by FDA for use in diagnosing the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback